NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/27/2025
Back to search
Official data from USPTO
TAILOR BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TAILOR BIO
ST13
US500000098549945Class
1, 5, 9, 35, 41, 42, 44
Filing
98549945
Registration
7806673
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
05/27/2025
Trademark type
Word
Nice classes
1, 5, 9, 35, 41, 42, 44
Filing date
05/14/2024
Registration date
05/27/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/27/2025
Last transaction
05/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Oakham, Rutland, GB
Examiner
DINALLO, KEVIN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
TAILOR BIO LTD
Representatives
Richard S. Finkelstein RC Trademark Company, LLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use; Diagnostic reagents and preparationsexcept for medical or veterinary use; Kits containing chemical reagents and a protocol for use thereof for non-medical purposes; Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use in the fields of nucleic acid sequencinggenotypingdiagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiology and metagenomicsbiotechnologyagricultureforensicsfood safetygenetic testinggenetics; Kits comprising nucleotidesreagentsenzyme substratesbufferschemical preparationsbiological preparations for scientific and research use including in the fields of nucleic acid sequencinggenotypingdiagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiology and metagenomicsbiotechnology.
Class 5
Pharmaceuticalsfor the treatment of cancers; Pharmaceutical drugsfor the treatment of cancers; Pharmaceutical preparations for the treatment of cancers; Pharmaceutical preparations for the treatment of cancers with chromosomal abnormalities; Pharmaceutical preparations for the treatment of cancers with chromosomal instabilities; Pharmaceutical preparations acting on cancers; Pharmaceutical preparations acting on cancers with chromosomal abnormalities; Pharmaceutical preparations acting on cancers with chromosomal instabilities; Medicinefor the treatment of cancers; Medicines for human purposesfor the treatment of cancers; Medicine for the treatment of cancers with chromosomal abnormalities; Medicine for the treatment of cancers with chromosomal instabilities; Chemicals for pharmaceutical usefor the treatment of cancers; Chemical reagents for medical use; Chemical preparations for medical purposesfor the treatment of cancers; Drugs for medical purposesfor the treatment of cancersDiagnostic reagents and preparations for medical or veterinary useKits containing chemical reagents and a protocol for use thereof for medical purposes
Class 9
Downloadable software for data analysis of the genome for chromosomal instabilities; Downloadable application software for data analysis of the genome for chromosomal instabilities; Downloadable computer software for data analysis of the genome for chromosomal instabilities; Downloadable bioinformatics software for data analysis of the genome for chromosomal instabilities; Downloadable computer software platforms for data analysis of the genome for chromosomal instabilities; Downloadable artificial intelligence software for data analysis of the genome for chromosomal instabilities; Downloadable artificial intelligence software platforms for data analysis of the genome for chromosomal instabilities; Downloadable artificial intelligence software for searchingtrackingexplorationanalysis of data for use in the field of healthcare; Downloadable artificial intelligence software for searchingtrackingexploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines for cancers with chromosomal abnormalities; Computer hardware and downloadable software for use with medical patient monitoring equipmentfor receivingprocessingtransmitting and displaying data; Scientific apparatus and instrumentsspectrometerscentrifugesmicroscopes for use in laboratory research; Scientific specimens for laboratory useprepared microscope slides and sample vials containing chemical reagents
Class 35
Database management; Database management and reporting services for business purposes; Business information services; Business consulting services; Business consulting services in the field of drug discovery; Business consulting services in the field of biomarker discovery; Business consulting services in the field of genomics; Business consulting in the field of chromosomal abnormalities; Market intelligence services; Data processing; Data processing in the field of drug discovery; Data processing in the field of medical diagnosis; Data processing in the field of biomarker discovery; Data processing in the field of genomics; Data processing in the field of bioinformatics; Data processing in the field of chromosomal abnormalities; Data processing in the field of chromosomal instabilities; Informationadvisory and consultancy services in relation to all of the aforesaid
Class 41
Publication of books; Publication of journals; Publication of electronic books and journals online; Publication of materialteaching materials that can be accessed from databases or from the Internet; Publication of scientific research findings; Publication of electronic books and journals featuring the results of clinical trials; Publication of electronic books and journals featuring the results of clinical trials for pharmaceutical preparations
Class 42
Compilation of data for use in scientific research; Data analysis in the field of genomics; Data analysis in the field of biomarker discovery; Scientific and technological servicesresearch in the fields of bioinformatics and drug discovery; Design and development of computer software; Providing online non-downloadable computer software for analyzing genomic and healthcare data; Platform as a Service PaaS featuring computer software platforms for data exploration and analysis in the field of healthcare; Platform as a Service PaaS featuring computer software platforms for data analysis in the research and development of pharmaceutical preparations; Software as a Service SaaS featuring computer software for data exploration in the field of healthcare; Software as a Service SaaS featuring artificial intelligence computer software for analyzing chromosomal abnormalities and instabilities; Medical and scientific research in the field of drug target discovery for development of pan-cancer precision therapies; Genetic engineering servicesscientific research in the field of genetic engineering; Scientific research in the field of genetics and drug discovery; Scientific research conducted using databases and the Internet in the field of genetics; Pharmaceutical research and development services; Drug discovery services; Scientific research and development; Consulting services in the fields of pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 44
Healthcare services; Healthcare informationadvisory and consultancy services for cancers with chromosomal abnormalities; Healthcare informationadvisory and consultancy services for cancers with chromosomal instabilities; Medical services; Medical informationadvisory and consultancy services for cancers with chromosomal abnormalities; Medical testing for diagnostic or treatment purposes; Pharmaceutical servicespharmaceutical compounding services; Pharmaceutical information relating to diagnostic properties of pharmaceuticals; Pharmaceutical advisory and consultancy services for cancers with chromosomal abnormalities; Pharmaceutical servicespharmaceutical advice; Pharmaceutical information relating toadvisory and consultancy services for cancers with chromosomal instabilities; Advisory and collation of medical information in the healthcare sector in the field of pharmaceuticals; Providing medical information in the healthcare sector; Providing medical information concerning pharmaceuticals and the research and development of pharmaceuticals for cancers with chromosomal abnormalities; Advisory and collation of information in the healthcare sector; Providing medical information concerning pharmaceuticals and the research and development of pharmaceuticals for cancers with chromosomal instabilities; Health consultancy; Medical treatment services; Provision of personalised medicine information in the field of rare diseases; Medical advisory services relating to rare diseases; Advisory services relating to treatment of rare diseases; Medical health assessment services; Advisory services relating to medical instrumentsproviding guidance on the selection and use of medical diagnostic instruments for healthcare professionals; Therapy servicesgene therapy services; Medical and health care services relating to DNAgenetics and genetic testing; Genetic testing for medical purposes; Providing cancers screening services
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/27/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/08/2025
PUBO
PUBLISHED FOR OPPOSITION
04/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/13/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/13/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/13/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/13/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/13/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/24/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/24/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2024
GNRT
NON-FINAL ACTION E-MAILED
12/09/2024
CNRT
NON-FINAL ACTION WRITTEN
12/09/2024
DOCK
ASSIGNED TO EXAMINER
11/27/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/14/2024
NWAP
NEW APPLICATION ENTERED
05/14/2024
Continuous trademark protection
Get notified about every new filing that threatens TAILOR BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.